APO RESEARCH · REPORT
ELISpot and FluoroSpot Assay
The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.
Product & engineering
Understand the product.
The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.
Selected research
Industry Research
ELISpot and FluoroSpot Assay Industry Research Report 2026
Market perspective
The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.
Global eLISpot and fluoroSpot assay main players include CP Kelco, DowDuPont (Danisco), Cargill, Herbstreith & Fox, Andre Group, Silvateam, Naturex, Ceamsa, Anhui Jinfeng Pectin, Pomona’s Universal Pectin, Anhui Yuning, Bio-Technology, etc., totally accounting for about 80%. North America is the largest market, with s share over 45%. As for the types of products, it can be divided into assay kit and analyzer. The most common product is assay kit, holding a share over 62%. In terms of applications, it is widely used in diagnostic and research. The most application is research, with a share over 64%.
Report Scope
Read the full market overview
This report quantifies the global ELISpot and FluoroSpot Assay market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to ELISpot and FluoroSpot Assay.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
ELISpot and FluoroSpot Assay Market by Company
Oxford Immunotec
Cellular Technology Limited
BD
AID GmbH
Mabtech
Bio-Techne
Lophius Biosciences
Abcam
Biotech Investissement Group
U-CyTech biosciences.
ELISpot and FluoroSpot Assay Segment by Type
Assay Kit
Analyzer
Others
ELISpot and FluoroSpot Assay Segment by Application
Diagnostic
Research
ELISpot and FluoroSpot Assay Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISpot and FluoroSpot Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ELISpot and FluoroSpot Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISpot and FluoroSpot Assay.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of ELISpot and FluoroSpot Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Assay Kit
- Analyzer
- Others
Applications
- Diagnostic
- Research
Companies covered
- Oxford Immunotec
- Cellular Technology Limited
- BD
- AID GmbH
- Mabtech
- Bio-Techne
- Lophius Biosciences
- Abcam
- Biotech Investissement Group
- U-CyTech biosciences.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 ELISpot and FluoroSpot Assay by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Assay Kit
- 2.2.3 Analyzer
- 2.2.4 Others
- 2.3 ELISpot and FluoroSpot Assay by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic
- 2.3.3 Research
- 2.4 Assumptions and Limitations
3 ELISpot and FluoroSpot Assay Breakdown Data by Type
- 3.1 Global ELISpot and FluoroSpot Assay Historic Market Size by Type (2021-2026)
- 3.2 Global ELISpot and FluoroSpot Assay Forecasted Market Size by Type (2027-2032)
4 ELISpot and FluoroSpot Assay Breakdown Data by Application
- 4.1 Global ELISpot and FluoroSpot Assay Historic Market Size by Application (2021-2026)
- 4.2 Global ELISpot and FluoroSpot Assay Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global ELISpot and FluoroSpot Assay Market Perspective (2021-2032)
- 5.2 Global ELISpot and FluoroSpot Assay Growth Trends by Region
- 5.2.1 Global ELISpot and FluoroSpot Assay Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 ELISpot and FluoroSpot Assay Historic Market Size by Region (2021-2026)
- 5.2.3 ELISpot and FluoroSpot Assay Forecasted Market Size by Region (2027-2032)
- 5.3 ELISpot and FluoroSpot Assay Market Dynamics
- 5.3.1 ELISpot and FluoroSpot Assay Industry Trends
- 5.3.2 ELISpot and FluoroSpot Assay Market Drivers
- 5.3.3 ELISpot and FluoroSpot Assay Market Challenges
- 5.3.4 ELISpot and FluoroSpot Assay Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top ELISpot and FluoroSpot Assay Players by Revenue
- 6.1.1 Global Top ELISpot and FluoroSpot Assay Players by Revenue (2021-2026)
- 6.1.2 Global ELISpot and FluoroSpot Assay Revenue Market Share by Players (2021-2026)
- 6.2 Global ELISpot and FluoroSpot Assay Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of ELISpot and FluoroSpot Assay Head Office and Area Served
- 6.4 Global ELISpot and FluoroSpot Assay Players, Product Type & Application
- 6.5 Global ELISpot and FluoroSpot Assay Manufacturers Established Date
- 6.6 Global ELISpot and FluoroSpot Assay Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America ELISpot and FluoroSpot Assay Market Size (2021-2032)
- 7.2 North America ELISpot and FluoroSpot Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America ELISpot and FluoroSpot Assay Market Size by Country (2021-2026)
- 7.4 North America ELISpot and FluoroSpot Assay Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe ELISpot and FluoroSpot Assay Market Size (2021-2032)
- 8.2 Europe ELISpot and FluoroSpot Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe ELISpot and FluoroSpot Assay Market Size by Country (2021-2026)
- 8.4 Europe ELISpot and FluoroSpot Assay Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific ELISpot and FluoroSpot Assay Market Size (2021-2032)
- 9.2 Asia-Pacific ELISpot and FluoroSpot Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific ELISpot and FluoroSpot Assay Market Size by Country (2021-2026)
- 9.4 Asia-Pacific ELISpot and FluoroSpot Assay Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America ELISpot and FluoroSpot Assay Market Size (2021-2032)
- 10.2 South America ELISpot and FluoroSpot Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America ELISpot and FluoroSpot Assay Market Size by Country (2021-2026)
- 10.4 South America ELISpot and FluoroSpot Assay Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa ELISpot and FluoroSpot Assay Market Size (2021-2032)
- 11.2 Middle East & Africa ELISpot and FluoroSpot Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa ELISpot and FluoroSpot Assay Market Size by Country (2021-2026)
- 11.4 Middle East & Africa ELISpot and FluoroSpot Assay Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Oxford Immunotec
- 12.1.1 Oxford Immunotec Company Information
- 12.1.2 Oxford Immunotec Business Overview
- 12.1.3 Oxford Immunotec Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.1.4 Oxford Immunotec ELISpot and FluoroSpot Assay Product Portfolio
- 12.1.5 Oxford Immunotec Recent Developments
- 12.2 Cellular Technology Limited
- 12.2.1 Cellular Technology Limited Company Information
- 12.2.2 Cellular Technology Limited Business Overview
- 12.2.3 Cellular Technology Limited Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.2.4 Cellular Technology Limited ELISpot and FluoroSpot Assay Product Portfolio
- 12.2.5 Cellular Technology Limited Recent Developments
- 12.3 BD
- 12.3.1 BD Company Information
- 12.3.2 BD Business Overview
- 12.3.3 BD Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.3.4 BD ELISpot and FluoroSpot Assay Product Portfolio
- 12.3.5 BD Recent Developments
- 12.4 AID GmbH
- 12.4.1 AID GmbH Company Information
- 12.4.2 AID GmbH Business Overview
- 12.4.3 AID GmbH Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.4.4 AID GmbH ELISpot and FluoroSpot Assay Product Portfolio
- 12.4.5 AID GmbH Recent Developments
- 12.5 Mabtech
- 12.5.1 Mabtech Company Information
- 12.5.2 Mabtech Business Overview
- 12.5.3 Mabtech Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.5.4 Mabtech ELISpot and FluoroSpot Assay Product Portfolio
- 12.5.5 Mabtech Recent Developments
- 12.6 Bio-Techne
- 12.6.1 Bio-Techne Company Information
- 12.6.2 Bio-Techne Business Overview
- 12.6.3 Bio-Techne Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.6.4 Bio-Techne ELISpot and FluoroSpot Assay Product Portfolio
- 12.6.5 Bio-Techne Recent Developments
- 12.7 Lophius Biosciences
- 12.7.1 Lophius Biosciences Company Information
- 12.7.2 Lophius Biosciences Business Overview
- 12.7.3 Lophius Biosciences Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.7.4 Lophius Biosciences ELISpot and FluoroSpot Assay Product Portfolio
- 12.7.5 Lophius Biosciences Recent Developments
- 12.8 Abcam
- 12.8.1 Abcam Company Information
- 12.8.2 Abcam Business Overview
- 12.8.3 Abcam Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.8.4 Abcam ELISpot and FluoroSpot Assay Product Portfolio
- 12.8.5 Abcam Recent Developments
- 12.9 Biotech Investissement Group
- 12.9.1 Biotech Investissement Group Company Information
- 12.9.2 Biotech Investissement Group Business Overview
- 12.9.3 Biotech Investissement Group Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.9.4 Biotech Investissement Group ELISpot and FluoroSpot Assay Product Portfolio
- 12.9.5 Biotech Investissement Group Recent Developments
- 12.10 U-CyTech biosciences.
- 12.10.1 U-CyTech biosciences. Company Information
- 12.10.2 U-CyTech biosciences. Business Overview
- 12.10.3 U-CyTech biosciences. Revenue in ELISpot and FluoroSpot Assay Business (2021-2026)
- 12.10.4 U-CyTech biosciences. ELISpot and FluoroSpot Assay Product Portfolio
- 12.10.5 U-CyTech biosciences. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst